Search
Now showing items 1-3 of 3
Inhibition of progestin-induced VEGF in mammary cancer by curcumin and 2-methoxy estradiol and their potential role as anti-angiogenic & chemopreventive compounds
(University of Missouri--Columbia, 2009)
Estrogen/Progestin combined hormone replacement therapy (HRT) is commonly prescribed to alleviate the symptoms of menopause in women. Combination HRT however is associated with an increased risk of breast cancer, an effect ...
Apigenin : chemopreventive and chemotherapeutic potential for progestin-dependent breast cancer
(University of Missouri--Columbia, 2012)
Use of estrogen-progestin hormone replacement therapy (HRT) has been linked to increased risk of breast cancer, an effect that has been attributed to the progestin component. Commonly available antiprogestins are associated ...
Cholesterol synthesis inhibitors prevent growth and metastasis of breast cancer cells
(University of Missouri--Columbia, 2017)
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Clinical trials and studies show that post-menopausal women undergoing hormone replacement therapy containing a combination of estrogen and progestin ...